血清学方法对评估肺炎衣原体与血管疾病之间联系的影响。
Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases.
作者信息
Maraha Boulos, den Heijer Martin, Kluytmans Jan, Peeters Marcel
机构信息
Regional Laboratory for Medical Microbiology, Dordrecht, The Netherlands.
出版信息
Clin Diagn Lab Immunol. 2004 Jul;11(4):789-91. doi: 10.1128/CDLI.11.4.789-791.2004.
Abstract
We assessed the impact of five serologic tests on the link between Chlamydia pneumoniae and abdominal aortic aneurysms (AAA). The results of the tests were inconsistent. Agreement among the five tests was generally poor. Detection of the link between C. pneumoniae and AAA depends on the serologic methodology chosen.
摘要
我们评估了五项血清学检测对肺炎衣原体与腹主动脉瘤（AAA）之间关联的影响。检测结果并不一致。这五项检测之间的一致性普遍较差。肺炎衣原体与腹主动脉瘤之间关联的检测取决于所选择的血清学方法。
相似文献
1
Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases.
Clin Diagn Lab Immunol. 2004 Jul;11(4):789-91. doi: 10.1128/CDLI.11.4.789-791.2004.
2
3
Anti chlamydia antibodies in patients with thoracic and abdominal aortic aneurysms.
Wien Klin Wochenschr. 2002 Dec 30;114(23-24):972-7.
4
The association between serological markers for Chlamydophila pneumoniae and the development of abdominal aortic aneurysm.
Ann Vasc Surg. 2011 Apr;25(3):322-6. doi: 10.1016/j.avsg.2010.09.001. Epub 2010 Dec 3.
5
[The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm].
Pol Merkur Lekarski. 2001 Dec;11(66):491-4.
6
The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm: case-control study.
Clin Infect Dis. 2000 Jun;30(6):946-7. doi: 10.1086/313806.
7
Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.
J Vasc Surg. 2001 Oct;34(4):606-10. doi: 10.1067/mva.2001.117891.
8
Chlamydia pneumoniae antibodies and C-reactive protein levels in patients with abdominal aortic aneurysms.
ScientificWorldJournal. 2013 Dec 28;2013:212450. doi: 10.1155/2013/212450. eCollection 2013.
9
Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae.
Respirology. 2008 May;13(3):427-31. doi: 10.1111/j.1440-1843.2007.01230.x.
10
Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms.
Eur J Vasc Endovasc Surg. 2000 Jun;19(6):630-5. doi: 10.1053/ejvs.1999.1057.
引用本文的文献
1
Circulating markers of abdominal aortic aneurysm presence and progression.
Circulation. 2008 Dec 2;118(23):2382-92. doi: 10.1161/CIRCULATIONAHA.108.802074.
2
Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology.
Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):141-5. doi: 10.1007/s10096-006-0245-5.
3
Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.
J Clin Microbiol. 2005 Jan;43(1):19-24. doi: 10.1128/JCM.43.1.19-24.2005.
本文引用的文献
1
Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis.
J Clin Microbiol. 2003 Sep;41(9):4049-53. doi: 10.1128/JCM.41.9.4049-4053.2003.
2
Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results?
Am Heart J. 2003 Mar;145(3):409-17. doi: 10.1067/mhj.2003.20.
3
Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.
J Clin Microbiol. 2002 May;40(5):1603-9. doi: 10.1128/JCM.40.5.1603-1609.2002.
4
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).
Clin Infect Dis. 2001 Aug 15;33(4):492-503. doi: 10.1086/322632. Epub 2001 Jul 20.
5
Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae.
Clin Diagn Lab Immunol. 2001 May;8(3):588-92. doi: 10.1128/CDLI.8.3.588-592.2001.
6
Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals.
J Clin Microbiol. 2001 May;39(5):1859-64. doi: 10.1128/JCM.39.5.1859-1864.2001.
7
Detection of Chlamydia pneumoniae DNA in buffy-coat samples of patients with abdominal aortic aneurysm.
Eur J Clin Microbiol Infect Dis. 2001 Feb;20(2):111-6. doi: 10.1007/pl00011240.
8
Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses.
Clin Infect Dis. 2000 Jul;31(1):3-6. doi: 10.1086/313911. Epub 2000 Jul 17.
9
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.
BMJ. 2000 Jul 22;321(7255):208-13. doi: 10.1136/bmj.321.7255.208.
10
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results.
J Infect Dis. 2000 Jun;181 Suppl 3:S426-9. doi: 10.1086/315603.
Zotero 插件